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Saliva and blood both provide high quality sources of DNA for whole exome sequencing, with no 72 difference in ability to resolve SNVs and deaminase-associated metrics. We did not identify somatic 73
SNVs when comparing blood and saliva of healthy individuals, and we conclude that more specialized 74 investigative methods are required to comprehensively assess the impact of deaminase activity on 75 genome stability in healthy individuals. 76 77 Background 78 APOBEC/AID deaminases are a recognized endogenous source of genome instability [1] [2] [3] [4] [5] . Somatic 79 mutations caused by deamination events have been identified in cancer in vitro and in vivo [6] [7] [8] [9] , and 80 evidence of deaminase-associated mutations in non-cancerous conditions is emerging, such as various 81 viral infections and neurodegenerative diseases [10, 11] . Deaminases have also recently been implicated 82 in accumulation of pre-cancerous mutations [12] , and as a causative driver of many human SNPs [13] . 83 84 Deaminases predominantly drive C-to-U(T) and A-to-I(G) transition mutations, however DNA repair 85 mechanisms typically prevent deamination from compromising genome integrity and causing somatic 86 mutation [14, 15] . Pathophysiological processes can disrupt normal DNA repair, resulting in mosaic 87 manifestation of deaminase-associated single nucleotide variants (SNVs) in affected tissues [16] . 88
Although deaminases employ similar biochemical mechanisms, each has a unique binding domain 89 associated with one or more DNA motifs [17, 18] . Deaminase motifs can be identified and quantified in 90
Next-Generation Sequencing (NGS) data facilitating diagnosis of the specific cause of the mutation. 91
For example, AID targets C-sites in the context of WRC motifs (W = A or T; R = A or G; reverse 92 complements as GYW, with Y = T or C), APOBEC3G deaminates CC sites (or GG) and APOBEC3B 93 deaminates TCW (or WGA) motifs and ADARs deaminate WA sites [2, 19, 20] . Establishing 94 reproducible and robust deaminase-associated SNV profiles in healthy people will improve the utility 95 of mutation profiling techniques for monitoring progression of diseases such as cancer, and for 96 understanding patient response to treatment. 97 98 Sampling of saliva or buccal cells is a widely employed technique for collecting human DNA for 99 ancestry, forensic, medical and research purposes [21, 22, 23, 24] . DNA extracted from saliva can be 100 analyzed using various NGS techniques, however the quality of DNA derived from saliva can be 101 compromised by metagenomic DNA and activity of various enzymes and antibacterial factors. There 102 are several practical advantages to this DNA source, such as ease of sampling and additional 103 sequencing information about metagenomic populations [25, 26, 27] , however DNA obtained from 104 saliva is not yet routinely used for detecting SNVs. 105 106 Here, we report profiles for SNVs associated with deaminase motifs for a cohort of 24 healthy human 107 subjects using whole exome sequencing (WES). For twelve of these subjects (Group 1) we compare 108 blood with biological and technical saliva replicates from Caucasian volunteers of different age groups 109 and sex and hypothesize that deaminase-associated SNV profiles of a cohort of healthy individuals will 110 show a high concordance between saliva and whole blood DNA in a reproducible and robust manner. 111
112

Methods
113
Healthy subject selection 114
In total, 24 healthy Caucasian subjects were recruited for this study. Volunteers were considered 115 healthy if they had blood pressure and heart rate within normal ranges, had never smoked, were only 116 light drinkers (<14 units of alcohol weekly), had no major viral infections or immune related diseases 117 and did not take any regular medication. Eight subjects were recruited into each of the three age groups 118 18-19, 30-39, and 50-59, with an equal ratio of males to females in each group. These subjects were 119 randomly allocated into two groups of equal sex and age group. Group 1 (n=12) SNVs occurring within four key deaminase motifs were identified and quantified. The motifs used 168 were AID: WRC / GYW, ADAR: WA / TW, APOBEC3G: CC / GG, APOBEC3B: TCW / WGA 169 where W=A or T, Y=C or T, R=A or G [2, 19, 20] . The base mutated in each motif is underlined. Motif 170 searches were conducted according to the direction of the gene. Transition/transversion ratios (Ti/Tv) 171 were calculated as the proportion of total transition variants. Strand bias was calculated as the 172 proportion of variants on the forward strand (e.g. C:G and A:T as percentages). Motif-independent 173 metrics and SNVs not associated with motifs of AID, ADAR, APOBEC3G or APOBEC3B (denoted 174 "Other") were also quantified. 175 176
Experimental design 177
Five WES datasets were generated for twelve subjects (Group 1), comprised of two males and two 178 females from three age categories (18-19, 30-39 and 50-59). As described in Figure 1 
Results
202
Blood and saliva whole exome sequencing 203
Saliva and blood samples from 12 healthy volunteers, Group 1 subjects, underwent sequencing and 204 analysis according to the workflow illustrated in Figure 1 . In addition, 12 exomes were obtained from 205
Saliva-1 samples from the remaining 12 recruited healthy volunteers, Group 2 subjects (Table 2) . For 206 all exomes sequenced (n=72), an average of 136 million high-quality 100bp paired-end reads were 207 obtained. The total number of reads, mapping rate and coverage statistics for all sequencing runs are 208 described in Supplementary Table 1 . Mapping rates were between 94.2% and 99.9% with a median of 209 98.9%. The median exome coverage rates were 97.2% (>30x) and 70.0% (>100x) of the exome. 210
Sample HP_4_1 produced the lowest number of reads and subsequently had the lowest sequencing 211 depth with 91.5% of the exome covered by >30x. Age group, sex, and counts for total SNVs, SNVs 212 within a coding region (referred to CDS), and percentages of variants within a coding sequence region 213 that correspond to known motifs for AID, ADAR, APOBEC3G and APOBEC3B are presented in 214 Tables 1 and 2 
226
SNV concordance between and within sample types 227
For Group 1 subjects (n=12), SNVs called in each sample were analyzed following the workflow 228 described in Figure 1 The mean number of somatic SNV candidates found in saliva was 149 (saliva=tumor, blood=normal), 273 those found in blood was 121 (blood=tumor, saliva=normal). There was no correlation detected 274 between the number of candidate somatic variants and the age of subjects. The average number of 275 candidate saliva-blood somatic SNVs was 158, 141 and 148, and blood-saliva averages were 119, 131 276 and 111 across the age groups 18-19, 30-39 and 50-59 respectively. A measure of technical noise is 277 given by the number of candidate somatic variants found in biological and technical saliva replicates, 278 which were on average 126 and 123 SNVs respectively (Supplementary Figure 5) . Supplementary Figure 3 ). Deaminase-associated SNVs at the genotype level were 295 highly concordant and similar to the percentage concordance of all CDS SNVs: AID (96.1%), ADAR 296 (97.0%), APOBEC3G (96.3%), APOBEC3B (96.2%) and CDS (96.6%) ( Supplementary Table 2 ). 297
Strand bias and transition/transversion ratios were calculated for each deaminase and are summarized 298 below (Table 3 ). In total, approximately 50% of the CDS SNVs correspond to AID, ADAR, 299 APOBEC3G and APOBEC3B deaminase motifs. The intraclass correlation coefficient (ICC) was used 300 to quantify the reproducibility of the deaminase metric calculations. The ICC values range between 301 0.958 and 0.989 for all SNVs, deaminase motifs and associated metrics, revealing a very high 302 consistency/reproducibility among the five samples. ICC calculations for a range of additional metrics 303 are reported in Supplementary Table 3 . 304 305 306 
Analysis of unmapped reads 316
The average number of unmapped reads was larger in saliva (60 WES datasets, mean=2,372,300, 317 98.4% mapping rate) than in blood (12 WES datasets, mean=334,182, 99.7% mapping rate), 318 corresponding to a six fold higher unmapped rate in saliva (1.63% unmapped) compared to blood 319 (0.27% unmapped). Overall, there is a 98.6% average mapping across all 72 samples and replicates 320
( Supplementary Table 1 ). Quality statistics for unmapped reads are summarized at 321 https://jpmam1.github.io/MultiQC/. Unmapped reads for volunteers HP_1 and HP_2 were extracted 322 and aligned to the nr protein database. with read alignment rate to the NCBI nr database larger in saliva 323 (41%) than in blood (33%). Reads that failed to align to NCBI nr were typically low quality. 324
Unmapped reads derived from saliva, but not blood, were predominantly found to contain reads 325 aligning to metagenomic species (Supplementary Figure 6) . 326 327 Discussion 328 AID, APOBEC3G, APOBEC3B and ADAR deaminases are implicated in 30%-40% of clinically cu-329 rated SNPs in the OMIM database [13] . However, there is a paucity of research on deaminase-330 associated motifs in healthy subjects. Here, we have investigated deaminase-associated signatures in 331 blood and saliva of healthy Caucasian subjects using whole exome sequencing. Our experimental de-332 sign provided a framework to quantify variance in all SNVs, SNVs within the coding sequence of 333 genes, deaminase-associated coding SNVs, and provided measures of deaminase strand-bias and transi-334 tion/transversion in a highly robust and reproducible manner. Using different biological and technical 335 sample replicates we explored differences between concordant and discordant SNV calls across the 24-336 subject cohort, showing strong intraclass correlation between sample replicates. No significant differ-337 ences in discordant SNV calls were detected in pairwise comparisons between sample types. The 338 sources of discordant SNVs were investigated and were found to be associated with low read depth, 339 high strand bias, and low genotype quality. Analysis of putative somatic variants showed no conclusive 340 evidence of somatic mutation when comparing blood and saliva samples. On average, approximately 341 2% of reads failed to align to the human genome, with reads derived from saliva samples primarily re-342 lated to metagenomic taxa associated with the oral microbiome [41, 42] . Here, we establish that saliva 343 and blood are both appropriate sources of DNA for WES analyses, with no detected difference in abil-344 ity to resolve SNVs and deaminase-associated signatures and metrics. 345
346
A key component of the experimental design in this study (Figure 1 Previous research has shown high quality DNA can be obtained from saliva and blood, with results 359 from whole exome sequencing found to be comparable for specific applications [25, 26, 43] . Due to oral 360 microbiome and off-target capture, the overall unmapped rate of saliva in this study was six fold higher 361 than that of blood (1.6% vs 0.3%), providing sufficient unmapped reads to perform a limited metage-362 nomic analysis. Given the importance of the relationship between the microbiome and immunity [44] , 363 the oral microbiome information provided from off-target saliva exome capture may prove useful for a 364 variety of applications in future studies (e.g. Kidd et al. [25] ). 365 366 Accumulation of a small number of 'age-related' (pre-or non-cancerous) somatic mutations has been 367 reported in several recent studies [16, 45, 46] . Despite our comprehensive analysis of WES data for 368 evidence of somatic mutations across different ages and sexes, we were unable to unambiguously 369 detect somatic mutations by comparing blood and saliva in these healthy individuals. Our use of Deaminase mutagenesis is associated with an increasing number of viral infections and cancer types 388 [6, 19, [51] [52] [53] [54] [55] [56] [57] [58] . With development of more advanced sequencing technologies, we will be able to detect 389 evidence of deaminase activity with greater accuracy and examine changes over time [1, 59, 60] . In ad-390 dition to the well-characterized effects of deaminases on genome stability in cancer, and more recently 391 in precancerous conditions [55,61,62], deaminases have emerged as a driving factor in many human 392 The data are not publicly available due to information that could compromise research participant 436 privacy and consent. The data that support the findings of this study are available on reasonable request 437 from the corresponding author NEH. 438 
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